Stage 3 Colon Cancer Treatment - Scott's Envita Review
The risk of severe side effects and the lackadaisical approach to risk management compelled Scott to discontinue conventional treatments and opt for a more targeted treatment approach. “To think that I would lose the ability to walk because I'd be in debilitating pain was just a horrifying thought to me,” said Scott Waxman, who traveled from Philadelphia to Envita Medical Centers, a Center of Excellence for Precision Integrative Oncology located in Scottsdale, Arizona.
Disclaimer: Individual results will vary. Envita makes no guarantees for outcomes. Each patient case is unique. Please consult your doctor before making any changes to your medical treatment. Not every patient is a candidate for care or achieves these results. Treatments used in this case may not all be FDA approved for the treatment of this condition.
Concern about Quality of Life
An emergency colonoscopy, prompted by Scott's complaints of difficulties in bowel movements, led to the diagnosis of colon cancer, which was determined to be stage 3 after a colon resection surgery. His surgery was followed by a recommendation for 12 rounds of standard maximum therapeutic dose chemotherapy at a noted cancer specialty facility, where his oncologist made him aware of the potential side effects. “I have existing neuropathy... but the possibility that my neuropathy could worsen as a result of chemotherapy was something I wasn't even aware of,” said Scott.
He felt that his concern regarding worsening neuropathy impacting his quality of life was met with indifference. “It came across as somewhat cavalier, but I think this is just their mindset,” said Scott, referring to his standard oncologist's response to his concern. His oncologist would consider changing Scott's chemotherapy protocol only if it reached the point where he was unable to walk. “I did experience a slight worsening of neuropathy just after a single round, so what was going to happen after 11 more? That was what really scared me,” added Scott, explaining the reason behind his decision to discontinue standard chemotherapy and look for other options.
Impressed with Envita's Custom-Developed Protocols
“At home, I'm a stage 3 colon cancer patient, and I will receive the exact same protocol as every other stage 3 colon cancer patient; it doesn't matter what their situation is, we're all going to get the exact same thing. Logically, that doesn't make sense,” said Scott, an attorney by profession. Envita's custom-developed treatment protocols appealed to his curious mind, as these customizations are designed to precisely target the unique set of causes responsible for triggering the disease in each individual patient.
Proprietary Treatments and Immunotherapies
A stronger immune system enhances the chances of sustaining lasting outcomes, as it is the first and last line of defense against cancer, which explains why each patient's treatment protocol at Envita includes some level of personalized immunotherapy. In Scott's case, he benefited greatly from Envita's proprietary treatments like GTFC™ (Genetically Targeted Fractionated Chemotherapy), which is designed to target cancerous cells without impacting the surrounding healthy cells and the immune system at large. “I am accustomed to concierge care at home; I have a concierge doctor, and this felt to me like concierge chemotherapy,” added Scott.
GTFC™ is based on an in-depth genomic analysis, which is crucial for highlighting the most appropriate chemotherapy agents for each individual patient. Equipped with this information, the Envita team is able to utilize metronomic dosages of a greater number of chemotherapy agents to potentiate treatment response and reduce the risk of severe side effects. “I managed to go for a hike with my dog every single day that I was in treatment,” said Scott, reiterating how Envita's customized protocols were designed to help him recover holistically without worsening his pre-existing conditions like neuropathy.
His Envita Connection
Scott had known about Envita for more than a decade, having heard about it on the radio. “It always seemed very interesting to me, but I'd never done any research because it didn't pertain to me,” said Scott, who finally began researching it after experiencing side effects from his first round of standard chemotherapy. Within 24 hours of a virtual consultation with Envita physicians, he had made up his mind to travel across the country to seek care at Envita, and he feels grateful to have made that decision. “I'm completely convinced that I made the right decision!” remarked Scott emphatically, as he gears up to live life with No Evidence of Disease.
Call Us Now
At Envita, our committed team of specialists, including oncologists, interventional radiologists, researchers, and pharmacists, undergo more than 1,500 hours of rigorous training in our unique, personalized precision integrative oncology approach. This comprehensive preparation enables us to craft individualized treatment plans focused on improving patients' quality of life, extending their survival, and reducing treatment-related side effects. For any inquiries about cancer therapies or to discover how we can support you, feel free to reach us at: 866-830-4576.
